NRGN and Alzheimer disease: Compared to controls, individuals with prodromal AD showed lower levels of NPTX2 and higher levels of 9 proteins (YWHAE, YWHAH, YWHAZ, NEFL, NRGN, GAP43, TPD52, VAPA and AKR1A1).